This framing is exactly how lots of people in the industry are thinking about AI right now, but I think it's wrong.
The way to adopt new science, new technology, new anything really, has always been that you validate it for small use cases, then expand usage from there. Test on mice, test in clinical trials, then go to market. There's no need to speculate about "too much" or "too little" usage. The right amount of usage is knowable - it's the amount which you've validated will actually work for your use case, in your industry, for your product and business.
The fact that AI discourse has devolved into a Pascal's Wager is saddening to see. And when people frame it this way in earnest, 100% of the time they're trying to sell me something.